• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HLS 3.52% $1.33

HEALIUS LIMITED - Charts / Financials

Healius Limited is an Australia-based healthcare company. The Company operates through... Healius Limited is an Australia-based healthcare company. The Company operates through two segments: Pathology and Imaging. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment is a provider of imaging and scanning services at standalone imaging sites, hospitals, and medical centers. The Company has a network of pathology laboratories, collection centers, and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. The Company’s brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. The Company provides healthcare services that are accessible and efficient while supporting the coordination and continuity of quality patient care.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 29/03/2024 (20 minute delay) ?
Day
Open $1.29   Day High $1.33   Day Low $1.28
Daily Volume 2406708
Bids   Sellers
Number Price Volume   Number Price Volume
1 $1.32 14040   1 $1.34 2163

Directors & Senior Management

Mr. Paul Anderson Chief Executive Officer, Managing Director
Mr. Stephen Humphries Chief Financial Officer, Joint Company Secretary, Group Executive, General Affairs
Mr. Prasad Arav Group Executive - Digital and Technology
Mr. Jon Eide Group Executive - Commercial and Customer
Dr. Phil Lucas Group Executive - Lumus Imaging
Mr. Arjun Narang Group Executive - Operations Transformation
Mr. Mark Neeham Group Executive - Government Affairs
Ms. Janet Payne Group Executive - Corporate Affairs
Dr. Jan Van Rooyen Group Executive, Healius Pathology
Ms. Mary Weaver Joint Company Secretary
Ms. Kathryn McKenzie Interim Non-Executive Independent Chairman of the Board
Mr. Ravi Jeyaraj Director
Dr. Michael Philip Stanford Non-Executive Director
Mr. Gordon Richard Davis Non-Executive Independent Director
Ms. Sally Louise Evans Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
$1.33
Change
0.045(3.52%)
Mkt cap ! $962.0M
Open High Low Value Volume
$1.29 $1.33 $1.28 $3.157M 2.406M

Buyers (Bids)

No. Vol. Price($)
1 14040 $1.32
 

Sellers (Offers)

Price($) Vol. No.
$1.34 2163 1
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
$1.33
  Change
0.045 ( 3.44 %)
Open High Low Volume
$1.29 $1.33 $1.28 563921
Last updated 15.59pm 29/03/2024 ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.